https://www.selleckchem.com/products/jh-re-06.html
Th), trabecular number (Tb.N), and bone mineral density, but increased trabecular separation (Tb.Sp) in the femur. Collectively, our findings showed that ES inhibited RANKL-activated osteoclast differentiation in bone marrow macrophages and prevented OVX-mediated bone loss in rats. These findings suggest that ES has the potential to be used as a therapeutic agent for bone-related diseases, such as osteoporosis. Oral diseases are associated with various systemic disorders. Our previous research revealed new insights into the close relat
Gefällt mir
Kommentar
Teilen
